About CardioMind
CardioMind is a Healthcare company based in Sunnyvale (United States) founded in 2003. Drug-eluting stents for small coronary lesions were developed. CardioMind has raised $75 million across 3 funding rounds from investors including De Novo Ventures, InterWest and Latterell Venture Partners. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is CardioMind, Inc. Its competitors include Silk Road Medical, HDL Therapeutics and Supira Medical; 3 of its 3 listed competitors have raised funding.
Company details
CardioMind was founded in 2003 in Sunnyvale, United States, within the medical device sector focused on cardiology. Specialized stent systems were developed for treating small coronary lesions that conventional stents could not effectively reach. Operations centered on innovative drug-eluting technologies to address challenging vascular conditions. The company was acquired by Biosensors in June 2010, concluding its independent activities.
- Headquarters Sunnyvale, United States
- SectorsHealthcare
- Website cardiomind.com
- Legal Name Cardiomind, Inc
- Total Equity Funding$75M (USD)
in 3 rounds
- Latest Funding Round$22M (USD), Series B
Mar 2008
- InvestorsDe Novo Ventures
& 5 more
Funding Insights of CardioMind
CardioMind has successfully raised a total of $75M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $22 million completed in March 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $75M
- Total Rounds 3
- Last Round Series B — $22M
- First Round $20M
(Jun 2007)
- Investors Count 6
All 3 funding rounds of CardioMind with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2008 | $22M | Series B | – | – | – |
| Jul 2007 | $33M | Series A | – | – | |
| Jun 2007 | $20M | Series A | – | – | – |
6 investors in total: 6 institutional.
Investors in CardioMind
CardioMind has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include De Novo Ventures, InterWest and Latterell Venture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| denovovc.com | ||||
Early-stage investing in IT and healthcare ventures. | interwest.com | |||
Early-stage healthcare startups are supported with venture capital. | lvpcapital.com | San Ramon, United States | ||
Venture capital and private equity investment firm | morgenthaler.com | Portola Valley, United States | ||
Early stage VC firm investing in the US | onset.com | Menlo Park, United States | ||
Venture capital fund focused on early-stage healthcare startups | svhealthinvestors.com | Boston, United States |
Investor details for CardioMind
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of CardioMind
3 dated milestones of CardioMind across 5 years, from founding to its latest funding, stage changes and deals.
- Founded CardioMind is founded.
- Funding First funding round of $20.0M.
- Funding Latest funding round, Series B, of $22.0M.
Competitors of CardioMind
CardioMind has 3 listed competitors in our database, 3 of them funded. They include Silk Road Medical, HDL Therapeutics and Supira Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| silkroadmed.com | 2007 | Sunnyvale, United States | $241.8M | 352 | Provider of neuroprotection devices for carotid artery disease | |
| hdltherapeutics.com | 2010 | Short Hills, United States | $17.79M | Therapy to reverse coronary atherosclerosis is developed using patient plasma. | ||
| supiramedical.com | 2016 | Campbell, United States | $240.5M | Developer of ventricular assist devices for coronary intervention and cardiogenic shock |
Detailed competitors of CardioMind
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as CardioMind (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about CardioMind
CardioMind was founded in 2003 and raised its 1st funding round 4 years after it was founded.
CardioMind is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
CardioMind is a funded company, having raised a total of $75M across 3 funding rounds to date. The company's 1st funding round was a Series A of $20M, raised on Jun 2007.
CardioMind was founded in 2003 in Sunnyvale, United States, within the medical device sector focused on cardiology. Specialized stent systems were developed for treating small coronary lesions that conventional stents could not effectively reach. Operations centered on innovative drug-eluting technologies to address challenging vascular conditions. The company was acquired by Biosensors in June 2010, concluding its independent activities.
CardioMind's top competitors include Silk Road Medical, Supira Medical and HDL Therapeutics.
CardioMind has 6 investors. Key investors include De Novo Ventures, InterWest, Latterell Venture Partners, Morgenthaler, and ONSET Ventures.
CardioMind operates through Cardiomind, Inc.